These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. Woodhouse KW; Hamilton P; Lennard A; Rawlins MD Eur J Clin Pharmacol; 1983; 24(2):283-5. PubMed ID: 6840181 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430 [TBL] [Abstract][Full Text] [Related]
7. The effect of food on oral melphalan absorption. Reece PA; Kotasek D; Morris RG; Dale BM; Sage RE Cancer Chemother Pharmacol; 1986; 16(2):194-7. PubMed ID: 3948305 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of high dose melphalan. Hersh MR; Ludden TM; Kuhn JG; Knight WA Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of melphalan in children following high-dose intravenous injection. Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma. Loos U; Musch E; Engel M; Hartlapp JH; Hügl E; Dengler HJ Eur J Clin Pharmacol; 1988; 35(2):187-93. PubMed ID: 3191937 [TBL] [Abstract][Full Text] [Related]
11. High dose melphalan in children with advanced malignant disease. A pharmacokinetic study. Ninane J; Baurain R; de Selys A; Trouet A; Cornu G Cancer Chemother Pharmacol; 1985; 15(3):263-7. PubMed ID: 4053270 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of high-dose melphalan in children and adults. Gouyette A; Hartmann O; Pico JL Cancer Chemother Pharmacol; 1986; 16(2):184-9. PubMed ID: 3948304 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy with melphalan. Howell SB; Pfeifle CE; Olshen RA Ann Intern Med; 1984 Jul; 101(1):14-8. PubMed ID: 6732077 [TBL] [Abstract][Full Text] [Related]
15. The disposition of intraperitoneal bleomycin, melphalan, and vinblastine in cancer patients. Alberts DS; Chen HS; Chang SY; Peng YM Recent Results Cancer Res; 1980; 74():293-9. PubMed ID: 6160601 [TBL] [Abstract][Full Text] [Related]
16. Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden. Osterborg A; Ahre A; Björkholm M; Björeman M; Brenning G; Gahrton G; Grimfors G; Gyllenhammar H; Hast R; Johansson B Acta Oncol; 1990; 29(6):727-31. PubMed ID: 2223143 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities. Briele HA; Djuric M; Jung DT; Mortell T; Patel MK; Das Gupta TK Cancer Res; 1985 Apr; 45(4):1885-9. PubMed ID: 3978649 [TBL] [Abstract][Full Text] [Related]
19. Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion. Choi KE; Ratain MJ; Williams SF; Golick JA; Beschorner JC; Fullem LJ; Bitran JD Cancer Res; 1989 Mar; 49(5):1318-21. PubMed ID: 2645050 [TBL] [Abstract][Full Text] [Related]
20. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]